2Westermann D,Kasner M, Steendijk P, et al.Role of left ventricular stiffness in heart failure with normal ejection fraction [J].Circulation, 2008,117(16) :2051-2060.
3Tan Y T,Wenzelburger F,Lee E,et al.The pathophysiology of heart failure with normal ejection fraction exercise eehocardiography reveals complex abnormalities of both systolic and diastolic ventricular func- tion involving torsion,untwist,and longitudinal motion[J].Joumal of the American College of Cardiology, 2009,54 ( 1 ) : 36-46.
4Paulus W J,Tschope C,Sanderson J E,et al.How to diagnose dias- tolic heart failure:a consensus statement on the diagnosis of heart failure with normal left ventricular rejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology[J].Eur Heart J, 2007,28 : 2539-2550.
5Bhatia R S,Tu J V,Lee D S,et al.Outcome of heart failure with preserved ejection fraction in a population-based study[J].N Engl J Med, 2006,355 (3) : 260-269.
6Dp Andrea A,Caso P,Romano S,et al.Association between lett atrial myocardial function and exercise capacity in patients with either idiopathic or ischemic dilated cardiomyopathy:a two-dimensionals peckle strain study[J].Int J Cardiol, 2009,132 (3) : 354-363.
7Portman MA. The adenine nucleotide anslocator: regulation and function during myocardial development and hypertrophy [ J ]. Clin Exp Pharmacol Physiol,2002,29(4) :334-338.
8Di Napoli P, Barsotti A. Prognostic relevance of metabolic approach in patients with heart failure[J]. Curr P harm Des,2009,15 (8) : 883-892.
9Vitale C, Wajngaten M, Sposato B, et al. Tfimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease[J]. Eur Heart J,2004,25:1814-1821.
10Fragasso G, Palloshi A, Puccetti P, et al. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure [ J ]. J Am Co]] Cardiol, 2006,48 : 992-998.
